Risk Factors for Chronic Prostatitis Patients in Northwest China
Unknown statusNCT06385977
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this observational study is to learn about the risk factors of lifestyle, medication and sexual habits in adult chronic prostatitis / chronic pelvic pain syndrome patients. The main questions it aims to answer are: * Is lifestyle, medication, and sexual habits related to chronic prostatitis / chronic pelvic pain syndrome * Is there any medication available to protect men from chronic prostatitis / chronic pelvic pain syndrome. Participants will: * Independently receive a survey questionnaire on lifestyle, medication, and sexual habits. * Symptomatic individuals will undergo additional prostate fluid examination for diagnosis. Researchers will compare healthy adult males to see if there are differences on lifestyle, medication and sexual habits between the two groups.
Study details
- Official title
- Risk Factors for Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients in Northwest China
- Interventions
- Behavioral: lifestyle
- Behavioral: sexual habits
- Drug: medication
- Sponsor
- Shaanxi Provincial People's Hospital
- Start date
- 2016-01
- Primary completion
- 2024-06-30
- Sex
- Male
- Age range
- from 18 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Discomfort or pain in the pelvic region or perineum; * Symptoms lasting for at least 3 months; * NIH-CPSI pain score of ≥ 4; * Controls are volunteers who do not present any prostatitis-related symptoms. Exclusion Criteria: * Prostate cancer; * Benign prostatic hyperplasia with a post-void residual urine volume of \>50 ml; * Acute urinary tract infection.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06385977